High-resolution microscopic images of T cells that have been engineered with TGF-beta SNIPRs (shown in red) as they bind to TGF-beta (shown in green). The SNIPRs activate once the receptors fold into ...
Over the last decade, antibodies that block extracellular receptors on our immune cells have redefined the treatment approach for certain cancers. Now, all eyes are on how using the opposite approach ...
Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...
Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as ...
A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.
Most cancer treatments – from chemotherapies to engineered immune cells – have a host of side effects, in large part because they affect healthy cells in the body at the same time as targeting tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results